Neurology:BMI影响腓骨肌萎缩症致残程度

2021-11-04 MedSci原创 MedSci原创

与年龄和性别匹配的健康儿童相比,患有 CMT 的儿童体重不足或肥胖的比例更高。与健康体重的 CMT 儿童相比,患有 CMT 的儿童中,体重不足或肥胖与更大的残疾相关。

Charcot-Marie-Tooth病(CMT)是最常见的遗传性神经肌肉疾病,约2500人中有1人患有广泛的表型变异,包括主要与周围神经系统运动和感觉缺陷相关的遗传性疾病。CMT的特点是从远端到近端肌肉体积减少、肌无力、感觉丧失、无反射、手足畸形,CMT的分类是基于神经损伤的类型、遗传模式和潜在的基因突变。超过100个基因位点与CMT相关。与外周髓鞘蛋白-22基因(PMP22)重复相关的最常见亚型CMT1A约占所有CMT的50%。体重指数(BMI)已显示影响健康儿童以及神经肌肉疾病儿童的功能,并可能影响CMT中的残疾。

Gabrielle A. Donlevy等调查了体重指数 (BMI) 与 Charcot-Marie-Tooth 病 (CMT) 儿童残疾之间的关联。

该研究对 477 名3 至 20 岁 CMT 患者和316 名年龄和性别匹配的健康儿童进行了横断面分析。BMI 根据国际肥胖工作组 (IOTF) 标准进行分类,并将 BMI 分类与健康儿童进行比较。IOTF 类别(成人等效 BMI 切点)为严重体重不足(BMI <17 kg/m 2)、体重不足(BMI ≥17–<18.5 kg/m 2)、健康体重(BMI ≥18.5–<25 kg/m 2) 、超重(BMI ≥25–<30 kg/m 2)和肥胖(BMI ≥30 kg/m 2)。0 至 44 分 CMT 儿科量表 (CMTPedS) 的分数是一种经过充分验证的残疾衡量标准,与 BMI 相关联。

根据BMI分类的CMTPedS残疾评分均值(标准误差)

CMTPedS项目得分按BMI分类的手灵巧性,肌肉力量和力量评分

研究发现患有 CMT 的儿童被归类为严重体重不足(5.7% 对 0.3%)、体重不足(10.3% 对 5.1%)和肥胖(7.3% 对 3.8%)的比例较高(p < 0.05)。少数患有 CMT 的儿童被归类为健康体重(61.8% 对 74.4%)(p < 0.05),组间超重比例相似(14.9% 对 16.5%)。体重类别的 CMTPedS 评分(平均值 ± SD)如下:严重体重不足 27 ± 9、体重不足 20 ± 8、健康体重 17 ± 9、超重 17 ± 9 和肥胖 22 ± 10。

CMTPedS 项目按BMI类别对平衡、耐力(6MWT)、步态、感觉(针刺、振动)进行评分。

与患有CMT的健康体重儿童相比,体重严重不足与残疾程度更高 ( p < 0.001) 相关,肥胖 ( p = 0.015) 也是如此。

与年龄和性别匹配的健康儿童相比,患有 CMT 的儿童体重不足或肥胖的比例更高。与健康体重的 CMT 儿童相比,患有 CMT 的儿童中,体重不足或肥胖与更大的残疾相关。

原文出处

Association Between Body Mass Index and Disability in Children With Charcot-Marie-Tooth Disease. Neurology Oct 2021, 97 (17) e1727-e1736; DOI: 10.1212/WNL.0000000000012725

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1641409, encodeId=f54f16414090f, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Wed Aug 31 10:16:46 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696015, encodeId=38eb16960153f, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Dec 16 09:16:46 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810538, encodeId=62c2181053835, content=<a href='/topic/show?id=4ac18534248' target=_blank style='color:#2F92EE;'>#腓骨肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85342, encryptionId=4ac18534248, topicName=腓骨肌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Tue Jul 05 12:16:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001592, encodeId=60bd2001592f4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Jul 21 02:16:46 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503185, encodeId=8b6f1503185ba, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Nov 05 16:16:46 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1641409, encodeId=f54f16414090f, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Wed Aug 31 10:16:46 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696015, encodeId=38eb16960153f, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Dec 16 09:16:46 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810538, encodeId=62c2181053835, content=<a href='/topic/show?id=4ac18534248' target=_blank style='color:#2F92EE;'>#腓骨肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85342, encryptionId=4ac18534248, topicName=腓骨肌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Tue Jul 05 12:16:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001592, encodeId=60bd2001592f4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Jul 21 02:16:46 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503185, encodeId=8b6f1503185ba, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Nov 05 16:16:46 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-12-16 chendoc252
  3. [GetPortalCommentsPageByObjectIdResponse(id=1641409, encodeId=f54f16414090f, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Wed Aug 31 10:16:46 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696015, encodeId=38eb16960153f, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Dec 16 09:16:46 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810538, encodeId=62c2181053835, content=<a href='/topic/show?id=4ac18534248' target=_blank style='color:#2F92EE;'>#腓骨肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85342, encryptionId=4ac18534248, topicName=腓骨肌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Tue Jul 05 12:16:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001592, encodeId=60bd2001592f4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Jul 21 02:16:46 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503185, encodeId=8b6f1503185ba, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Nov 05 16:16:46 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2022-07-05 amyloid
  4. [GetPortalCommentsPageByObjectIdResponse(id=1641409, encodeId=f54f16414090f, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Wed Aug 31 10:16:46 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696015, encodeId=38eb16960153f, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Dec 16 09:16:46 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810538, encodeId=62c2181053835, content=<a href='/topic/show?id=4ac18534248' target=_blank style='color:#2F92EE;'>#腓骨肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85342, encryptionId=4ac18534248, topicName=腓骨肌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Tue Jul 05 12:16:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001592, encodeId=60bd2001592f4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Jul 21 02:16:46 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503185, encodeId=8b6f1503185ba, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Nov 05 16:16:46 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2022-07-21 yinhl1978
  5. [GetPortalCommentsPageByObjectIdResponse(id=1641409, encodeId=f54f16414090f, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Wed Aug 31 10:16:46 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696015, encodeId=38eb16960153f, content=<a href='/topic/show?id=03b98809697' target=_blank style='color:#2F92EE;'>#萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88096, encryptionId=03b98809697, topicName=萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53fc29868494, createdName=chendoc252, createdTime=Thu Dec 16 09:16:46 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810538, encodeId=62c2181053835, content=<a href='/topic/show?id=4ac18534248' target=_blank style='color:#2F92EE;'>#腓骨肌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85342, encryptionId=4ac18534248, topicName=腓骨肌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=325a197, createdName=amyloid, createdTime=Tue Jul 05 12:16:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001592, encodeId=60bd2001592f4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Jul 21 02:16:46 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503185, encodeId=8b6f1503185ba, content=<a href='/topic/show?id=a71481058ca' target=_blank style='color:#2F92EE;'>#肌萎缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81058, encryptionId=a71481058ca, topicName=肌萎缩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eebd9606217, createdName=neizongke, createdTime=Fri Nov 05 16:16:46 CST 2021, time=2021-11-05, status=1, ipAttribution=)]

相关资讯

Neurology:青春期和青春期体重指数与多发性硬化症长期风险的关系:一项基于人群的研究

多发性硬化症(MS)是一种慢性、炎性和脱髓鞘的中枢神经系统(CNS)疾病,通常影响年轻人。无论是男性还是女性,14-24岁的高BMI与晚年患多发性硬化症的风险增加有关。

Sci Rep:出生顺序会影响身体质量指数(BMI)和胰岛素敏感性吗?

对50个超重的中年男子所做的一项研究表明,第一个出生的人比第二个出生的人更可能有较大的身体质量指数(BMI)和对胰岛素的较低敏感性。发表在本期Scientific Reports上的这项研究增进了我们对出生顺序的潜在长期健康影响的认识,尽管还需要进行将“同胞对”包括在内的更大规模的研究来全面评估这一联系。 一些证据表明,出生顺序从婴儿期到成年早期可能会影响代谢和身体组成,但中年时期的潜在影响此前

Stroke:房颤患者中,较高的BMI或降低脑血管事件风险

房颤患者中,较高的BMI或降低脑血管事件风险

Alzheimers Dementia: 注意:肚子越大,越容易痴呆!

小心:肚子越大,越容易痴呆!